In this article we will dive into PROGYNY INC (NASDAQ:PGNY) as a possible candidate for quality investing. Investors should always do their own research, but we noticed PROGYNY INC showing up in our Caviar Cruise quality screen, which makes it worth to investigate a bit more.
What matters for quality investors.
PGNY has shown strong performance in revenue growth over the past 5 years, with a 38.42% increase. This indicates the company's ability to generate consistent revenue growth and reflects its potential for long-term success.
PGNY exhibits a strong ROIC excluding cash and goodwill, indicating efficient capital utilization and profitable operations. The 26.65% reflects the company's ability to generate returns on invested capital and underscores its commitment to delivering value to shareholders.
With a favorable Debt/Free Cash Flow Ratio of 0.0, PGNY showcases its sound financial discipline and cash flow management. This ratio indicates the company's ability to service its debt obligations while maintaining sufficient free cash flow for future investments or operational needs.
PGNY demonstrates consistent Profit Quality over the past 5 years, with a strong 197.0%. This indicates the company's ability to generate sustainable and reliable profits, showcasing its long-term profitability and financial stability.
The 5-year EBIT growth of PGNY has been remarkable, with 41.01% increase. This demonstrates the company's ability to improve its operational efficiency and indicates its competitiveness within the market.
PGNY demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.
A complete fundamental analysis of PGNY
ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.
Overall PGNY gets a fundamental rating of 7 out of 10. We evaluated PGNY against 107 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making PGNY a very profitable company, without any liquidiy or solvency issues. PGNY is not valued too expensively and it also shows a decent growth rate. These ratings would make PGNY suitable for quality investing!
This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.